{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:22Z","timestamp":1793908642179,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03645-6","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T02:04:17Z","timestamp":1765764257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cross-sectional and longitudinal associations between fatty liver index and kidney function using updated MASLD and CKD\u2013EPI 2021 definitions: a population-based study with region-specific cutoffs"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-0924","authenticated-orcid":false,"given":"Sina","family":"Bazmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Fardaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Homayounfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Pezeshki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrollah","family":"Ghahramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Farjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"1","key":"3645_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"3645_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12882-025-04028-z","volume":"26","author":"J Guo","year":"2025","unstructured":"Guo J, Jiao W, Xia S, Xiang X, Zhang Y, Ge X, et al. The global, regional, and national patterns of change in the burden of chronic kidney disease from 1990 to 2021. BMC Nephrol. 2025;26(1):136.","journal-title":"BMC Nephrol"},{"issue":"10","key":"3645_CR3","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/ndt\/gfae048","volume":"39","author":"R Duff","year":"2024","unstructured":"Duff R, Awofala O, Arshad MT, Lambourg E, Gallacher P, Dhaun N, et al. Global health inequalities of chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2024;39(10):1692\u2013709.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3645_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/1744-9987.12716","volume":"22","author":"S Bouya","year":"2018","unstructured":"Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of chronic kidney disease in Iranian general population: a meta-analysis and systematic review. Ther Apher Dial. 2018;22(6):594\u20139.","journal-title":"Ther Apher Dial"},{"key":"3645_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;31:S32.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"3645_CR6","doi-asserted-by":"publisher","first-page":"101209","DOI":"10.1016\/j.jceh.2023.06.009","volume":"14","author":"SP Tabaeian","year":"2024","unstructured":"Tabaeian SP, Rezapour A, Azari S, Martini M, Saran M, Behzadifar M, et al. Prevalence of Non-alcoholic fatty liver disease in Iran: a systematic review and meta-analysis. J Clin Exp Hepatol. 2024;14(1):101209.","journal-title":"J Clin Exp Hepatol"},{"key":"3645_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"40","key":"3645_CR8","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the Fatty Liver Index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore). 2015;94(40):e1682.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3645_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13293-024-00617-z","volume":"15","author":"L Crudele","year":"2024","unstructured":"Crudele L, De Matteis C, Novielli F, Di Buduo E, Petruzzelli S, De Giorgi A, et al. Fatty liver index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men. Biol Sex Differ. 2024;15(1):43.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"3645_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"W-K Chan","year":"2023","unstructured":"Chan W-K, Chuah K-H, Rajaram RB, Lim L-L, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197.","journal-title":"J Obes Metab Syndr"},{"key":"3645_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072486","author":"RG Bogdan","year":"2025","unstructured":"Bogdan RG, Boicean A, Anderco P, Ichim C, Iliescu-Glaja M, Todor SB, et al. From liver to kidney: the overlooked burden of nonalcoholic fatty liver disease in chronic kidney disease. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14072486.","journal-title":"J Clin Med"},{"issue":"3","key":"3645_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1681\/ASN.2009080820","volume":"21","author":"JH Ix","year":"2010","unstructured":"Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010;21(3):406\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"3645_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101370","author":"I Umbro","year":"2021","unstructured":"Umbro I, Baratta F, Angelico F, Del Ben M. Nonalcoholic fatty liver disease and the kidney: a review. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9101370.","journal-title":"Biomedicines"},{"issue":"5","key":"3645_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/ndt\/gfac266","volume":"38","author":"X Cai","year":"2023","unstructured":"Cai X, Thorand B, Hohenester S, Koenig W, Rathmann W, Peters A, et al. Association between the fatty liver index and chronic kidney disease: the population-based KORA study. Nephrol Dial Transplant. 2023;38(5):1240\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3645_CR15","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.diabet.2023.101454","volume":"49","author":"GE Chung","year":"2023","unstructured":"Chung GE, Han K, Lee K-N, Bae JH, Yang SY, Choi S-Y, et al. Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: a nationwide population-based study. Diabetes Metab. 2023;49(4):101454.","journal-title":"Diabetes Metab"},{"issue":"7","key":"3645_CR16","doi-asserted-by":"publisher","first-page":"e0180951","DOI":"10.1371\/journal.pone.0180951","volume":"12","author":"JH Huh","year":"2017","unstructured":"Huh JH, Kim JY, Choi E, Kim JS, Chang Y, Sung K-C. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. PLoS ONE. 2017;12(7):e0180951.","journal-title":"PLoS ONE"},{"issue":"1","key":"3645_CR17","doi-asserted-by":"publisher","first-page":"21189","DOI":"10.1038\/s41598-024-72482-0","volume":"14","author":"Y-J Lee","year":"2024","unstructured":"Lee Y-J, Kim KM, Ko NG, Jin M, Na JH, Park IH. Effects of MAFLD defined by fatty liver index or ultrasonography on kidney function decline in the general population. Sci Rep. 2024;14(1):21189.","journal-title":"Sci Rep"},{"issue":"3","key":"3645_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2023.12.009","volume":"105","author":"X Li","year":"2024","unstructured":"Li X, Bhattacharya D, Yuan Y, Wei C, Zhong F, Ding F, et al. Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH). Kidney Int. 2024;105(3):540\u201361.","journal-title":"Kidney Int"},{"issue":"1","key":"3645_CR19","first-page":"13","volume":"56","author":"CH Park","year":"2025","unstructured":"Park CH, Lim H, Kim YN, Kim JY, Kim HW, Chang TI, et al. Non-alcoholic fatty liver disease and its association with kidney and cardiovascular outcomes in moderate to advanced chronic kidney disease. Am J Nephrol. 2025;56(1):13\u201324.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3645_CR20","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1038\/s41598-021-88025-w","volume":"11","author":"S Takahashi","year":"2021","unstructured":"Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, et al. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Sci Rep. 2021;11(1):8606.","journal-title":"Sci Rep"},{"issue":"5","key":"3645_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.21037\/hbsn-23-558","volume":"13","author":"JH Heo","year":"2024","unstructured":"Heo JH, Lee MY, Kim SH, Zheng MH, Byrne CD, Targher G, et al. Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study. Hepatobiliary Surg Nutr. 2024;13(5):801\u201313.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"3645_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12882-024-03910-6","volume":"25","author":"W Liu","year":"2024","unstructured":"Liu W, Sun X. Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies. BMC Nephrol. 2024;25(1):467.","journal-title":"BMC Nephrol"},{"issue":"5","key":"3645_CR23","doi-asserted-by":"publisher","first-page":"101512","DOI":"10.1016\/j.aohep.2024.101512","volume":"29","author":"Z Pan","year":"2024","unstructured":"Pan Z, Derbala M, AlNaamani K, Ghazinian H, Fan J-G, Eslam M. MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease. Ann Hepatol. 2024;29(5):101512.","journal-title":"Ann Hepatol"},{"issue":"4","key":"3645_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3645_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study. BMC Public Health. 2016;16(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"3","key":"3645_CR26","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/ije\/dyac241","volume":"52","author":"R Homayounfar","year":"2023","unstructured":"Homayounfar R, Farjam M, Bahramali E, Sharafi M, Poustchi H, Malekzadeh R, et al. Cohort profile: the Fasa adults cohort study (FACS): a prospective study of non-communicable diseases risks. Int J Epidemiol. 2023;52(3):e172\u20138.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"3645_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/odi.15189","volume":"31","author":"S Bazmi","year":"2025","unstructured":"Bazmi S, Mohammadi Z, Tabrizi R, Kazemi M. Recurrent aphthous stomatitis and sleep quality factors: a comprehensive analysis. Oral Dis. 2025;31(4):1215\u201327.","journal-title":"Oral Dis"},{"issue":"11","key":"3645_CR28","first-page":"791","volume":"19","author":"M Sartipi","year":"2016","unstructured":"Sartipi M, Nedjat S, Mansournia MA, Baigi V, Fotouhi A. Assets as a socioeconomic status index: categorical principal components analysis vs. latent class analysis. Arch Iran Med. 2016;19(11):791\u20136.","journal-title":"Arch Iran Med"},{"issue":"1","key":"3645_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12937-024-00938-0","volume":"23","author":"S Eghtesad","year":"2024","unstructured":"Eghtesad S, Masoudi S, Sharafkhah M, Rashidkhani B, Esmaeili-Nadimi A, Najafi F, et al. Validity and reproducibility of the PERSIAN cohort food frequency questionnaire: assessment of major dietary patterns. Nutr J. 2024;23(1):35.","journal-title":"Nutr J"},{"issue":"8","key":"3645_CR30","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073\u201380.","journal-title":"World Appl Sci J"},{"issue":"3","key":"3645_CR31","doi-asserted-by":"publisher","first-page":"e0300201","DOI":"10.1371\/journal.pone.0300201","volume":"19","author":"A Andishgar","year":"2024","unstructured":"Andishgar A, Bazmi S, Tabrizi R, Rismani M, Keshavarzian O, Pezeshki B, et al. Machine learning-based models to predict the conversion of normal blood pressure to hypertension within 5-year follow-up. PLoS ONE. 2024;19(3):e0300201.","journal-title":"PLoS ONE"},{"issue":"4s","key":"3645_CR32","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117-s314.","journal-title":"Kidney Int"},{"issue":"19","key":"3645_CR33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"1","key":"3645_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s12882-025-04537-x","volume":"26","author":"S Bazmi","year":"2025","unstructured":"Bazmi S, Ghahramani N, Farjam M. Inappropriate GFR equations misrepresent CKD epidemiology and risk interpretation in scientific reports. BMC Nephrol. 2025;26(1):596.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3645_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12876-024-03535-x","volume":"24","author":"A Saberian","year":"2024","unstructured":"Saberian A, Dehghan A, Homayounfar R, Kaffashan S, Zarei F, Niknejad S, et al. Determining the sensitivity and specificity of the calculated fatty liver index in comparison with ultrasound. BMC Gastroenterol. 2024;24(1):443.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"3645_CR36","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023\u201330.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3645_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3645_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/DMSO.S189544","volume":"12","author":"AR Khang","year":"2019","unstructured":"Khang AR, Lee HW, Yi D, Kang YH, Son SM. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. Diabetes Metab Syndr Obes. 2019;12:181\u201390.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3645_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13213316","author":"T Biciusca","year":"2023","unstructured":"Biciusca T, Stan SI, Balteanu MA, Cioboata R, Ghenea AE, Danoiu S, et al. The role of the fatty liver index (FLI) in the management of non-alcoholic fatty liver disease: a systematic review. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics13213316.","journal-title":"Diagnostics"},{"issue":"1","key":"3645_CR40","doi-asserted-by":"publisher","first-page":"42399","DOI":"10.1038\/s41598-025-26483-2","volume":"15","author":"S Bazmi","year":"2025","unstructured":"Bazmi S, Soleimani-Meigoli MS, Fardaei M, Mohammadi Z, Homayounfar R, Kazemi M, et al. Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles. Sci Rep. 2025;15(1):42399.","journal-title":"Sci Rep"},{"issue":"10","key":"3645_CR41","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s10157-025-02720-w","volume":"29","author":"S Gholipour","year":"2025","unstructured":"Gholipour S, Mohammadi Z, Bazmi S, Farahvashi P, Tabrizi R. Association of sleep parameters with kidney function: analysis of baseline data from 9216 adults in the Fasa Adult Cohort Study (FACS). Clin Exp Nephrol. 2025;29(10):1409\u201324.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"3645_CR42","doi-asserted-by":"publisher","first-page":"e101021","DOI":"10.1136\/bmjopen-2025-101021","volume":"15","author":"S Bazmi","year":"2025","unstructured":"Bazmi S, Mohammadi Z, Motazedian M, Tabrizi R. Is anaemia associated with QTc prolongation? A retrospective cross-sectional analysis from a rural population-based cohort. BMJ Open. 2025;15(9):e101021.","journal-title":"BMJ Open"},{"issue":"6","key":"3645_CR43","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/jcm13061616","volume":"13","author":"HH Lee","year":"2024","unstructured":"Lee HH, Ro H, Jung JY, Chang JH, Chung W, Kim AJ. The fatty liver index\u2019s association with incident chronic kidney disease in Korean middle-aged adults: a community-based cohort study. J Clin Med. 2024;13(6):1616.","journal-title":"J Clin Med"},{"issue":"4","key":"3645_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"T-Y Wang","year":"2022","unstructured":"Wang T-Y, Wang R-F, Bu Z-Y, Targher G, Byrne CD, Sun D-Q, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3645_CR45","doi-asserted-by":"publisher","first-page":"e45050","DOI":"10.2196\/45050","volume":"9","author":"S Wei","year":"2023","unstructured":"Wei S, Song J, Xie Y, Huang J, Yang J. The role of metabolic dysfunction\u2013associated fatty liver disease in developing chronic kidney disease: longitudinal cohort study. JMIR Public Health Surveill. 2023;9(1):e45050.","journal-title":"JMIR Public Health Surveill"},{"issue":"5","key":"3645_CR46","doi-asserted-by":"publisher","first-page":"e032604","DOI":"10.1161\/JAHA.123.032604","volume":"13","author":"J Gao","year":"2024","unstructured":"Gao J, Li Y, Zhang Y, Zhan X, Tian X, Li J, et al. Severity and remission of metabolic dysfunction\u2013associated fatty\/steatotic liver disease with chronic kidney disease occurrence. J Am Heart Assoc. 2024;13(5):e032604.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3645_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1186\/s12889-025-22188-3","volume":"25","author":"J Bai","year":"2025","unstructured":"Bai J, Zhang L, Zhang M, Hao Y, Yi Z, Zhou Y. Regional insights into the relationship between metabolic associated steatotic liver disease and chronic kidney disease: a socioeconomic perspective on disease correlation. BMC Public Health. 2025;25(1):993.","journal-title":"BMC Public Health"},{"issue":"9","key":"3645_CR48","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","volume":"70","author":"JM Weinberg","year":"2006","unstructured":"Weinberg JM. Lipotoxicity. Kidney Int. 2006;70(9):1560\u20136.","journal-title":"Kidney Int"},{"issue":"17","key":"3645_CR49","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3748\/wjg.v27.i17.1864","volume":"27","author":"R Heda","year":"2021","unstructured":"Heda R, Yazawa M, Shi M, Bhaskaran M, Aloor FZ, Thuluvath PJ, et al. Non-alcoholic fatty liver and chronic kidney disease: retrospect, introspect, and prospect. World J Gastroenterol. 2021;27(17):1864\u201382.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3645_CR50","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","volume":"50","author":"J Bilson","year":"2024","unstructured":"Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1):101506.","journal-title":"Diabetes Metab"},{"key":"3645_CR51","doi-asserted-by":"publisher","first-page":"155630","DOI":"10.1016\/j.metabol.2023.155630","volume":"145","author":"A Marsal-Beltran","year":"2023","unstructured":"Marsal-Beltran A, Rodr\u00edguez-Castellano A, Astiarraga B, Calvo E, Rada P, Madeira A, et al. Protective effects of the succinate\/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism. 2023;145:155630.","journal-title":"Metabolism"},{"issue":"2","key":"3645_CR52","doi-asserted-by":"publisher","first-page":"C467","DOI":"10.1152\/ajpcell.00327.2022","volume":"324","author":"M Pu","year":"2023","unstructured":"Pu M, Zhang J, Zeng Y, Hong F, Qi W, Yang X, et al. Succinate-SUCNR1 induces renal tubular cell apoptosis. Am J Physiol Cell Physiol. 2023;324(2):C467\u201376.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"3645_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han E, Lee YH. Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metab J. 2017;41(6):430\u20137.","journal-title":"Diabetes Metab J"},{"key":"3645_CR54","doi-asserted-by":"publisher","first-page":"1001365","DOI":"10.37349\/emed.2025.1001365","volume":"6","author":"C Acierno","year":"2025","unstructured":"Acierno C, Nevola R, Barletta F, Zieli\u0144ska K, Rinaldi L, Sasso FC, et al. The transition from NAFLD to MASLD: implications for diagnosis, prognosis, and clinical management. Explor Med. 2025;6:1001365.","journal-title":"Explor Med"},{"issue":"1","key":"3645_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2021.0188","volume":"28","author":"H Lin","year":"2022","unstructured":"Lin H, Wong GL, Zhang X, Yip TC, Liu K, Tse YK, et al. U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases. Clin Mol Hepatol. 2022;28(1):77\u201390.","journal-title":"Clin Mol Hepatol"},{"key":"3645_CR56","doi-asserted-by":"publisher","first-page":"872918","DOI":"10.3389\/fendo.2022.872918","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Xu G. Update on pathogenesis of glomerular hyperfiltration in early diabetic kidney disease. Front Endocrinol. 2022;13:872918.","journal-title":"Front Endocrinol"},{"issue":"8","key":"3645_CR57","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14943","volume":"41","author":"P Burra","year":"2021","unstructured":"Burra P, Bizzaro D, Gonta A, Shalaby S, Gambato M, Morelli MC, et al. Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int. 2021;41(8):1713\u201333.","journal-title":"Liver Int"},{"issue":"7","key":"3645_CR58","doi-asserted-by":"publisher","first-page":"514","DOI":"10.21037\/atm.2020.01.23","volume":"8","author":"RC Harris","year":"2020","unstructured":"Harris RC, Zhang MZ. The role of gender disparities in kidney injury. Ann Transl Med. 2020;8(7):514.","journal-title":"Ann Transl Med"},{"issue":"3","key":"3645_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/endocrines2030019","volume":"2","author":"A Franco-Acevedo","year":"2021","unstructured":"Franco-Acevedo A, Echavarria R, Melo Z. Sex differences in renal function: participation of gonadal hormones and prolactin. Endocrines. 2021;2(3):185\u2013202.","journal-title":"Endocrines"},{"issue":"5","key":"3645_CR60","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ackd.2013.05.004","volume":"20","author":"J Neugarten","year":"2013","unstructured":"Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20(5):390\u20135.","journal-title":"Adv Chronic Kidney Dis"},{"key":"3645_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103938","author":"G Li","year":"2025","unstructured":"Li G, Xu Z, Yang H, Zhang D, Liu B, Song Y, et al. Sex-specific mechanisms in the pathogenesis and progression of chronic kidney disease. Autoimmun Rev. 2025. https:\/\/doi.org\/10.1016\/j.autrev.2025.103938.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3645_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40001-023-01114-6","volume":"28","author":"C Roderburg","year":"2023","unstructured":"Roderburg C, Krieg S, Krieg A, Demir M, Luedde T, Kostev K, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD). Eur J Med Res. 2023;28(1):153.","journal-title":"Eur J Med Res"},{"issue":"9","key":"3645_CR63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1159\/000546354","volume":"149","author":"J Sandino-P\u00e9rez","year":"2025","unstructured":"Sandino-P\u00e9rez J, Gonz\u00e1lez-Garc\u00eda C, Hern\u00e1ndez Velasco PJ, Morales E, Sandino J. What is the role of sex differences in obesity-associated chronic kidney disease? Nephron. 2025;149(9):530\u20138.","journal-title":"Nephron"},{"issue":"11","key":"3645_CR64","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"issue":"4","key":"3645_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473\u201381.","journal-title":"J Clin Invest"},{"key":"3645_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2016-000143","author":"SR Bird","year":"2017","unstructured":"Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017. https:\/\/doi.org\/10.1136\/bmjsem-2016-000143.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"4","key":"3645_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1507\/endocrj.EJ21-0563","volume":"69","author":"S Takahashi","year":"2022","unstructured":"Takahashi S, Tanaka M, Higashiura Y, Mori K, Hanawa N, Ohnishi H, et al. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. Endocr J. 2022;69(4):463\u201371.","journal-title":"Endocr J"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:03:41Z","timestamp":1767863021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03645-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study met the principles outlined in the Helsinki Declaration, and all volunteers were informed about the research purpose and provided written consent before participating. The research procedure received approval by the Fasa University of Medical Sciences research ethics committees (IR.FUMS.REC.1400.015), which function similar to institutional review boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}